Growth stimulation of intestinal commensal Escherichia coli by catecholamines: A possible contributory factor in trauma-induced sepsis

Shock

Volumn 18, Issue 5, 2002, Pages 465-470

  Freestone, Primrose P ^a   Williams, Peter H ^a   Haigh, Richard D ^a   Maggs, Anthony F ^a,d   Neal, Christopher P ^a   Lyte, Mark ^b,c  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

^c MINNESOTA STATE UNIVERSITY MANKATO   (United States)

^d TORBAY HOSPITAL   (United Kingdom)

Author keywords

Catecholamines; Commensal bacteria; Infection; Iron; Stress response; Trauma

Indexed keywords

CATECHOLAMINE; IRON; NORADRENALIN;

ARTICLE; BIOLOGICAL MODEL; DRUG EFFECT; ESCHERICHIA COLI; GROWTH, DEVELOPMENT AND AGING; HUMAN; IN VITRO STUDY; INJURY; INTESTINE; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; SEPSIS;

CATECHOLAMINES; ESCHERICHIA COLI; HUMANS; INTESTINES; IRON; MODELS, BIOLOGICAL; NOREPINEPHRINE; SEPSIS; WOUNDS AND INJURIES;

EID: 0036835441     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-200211000-00014     Document Type: Article

References (51)

1. Assalia A, Bitterman H, Hirsh TM, et al: Influence of hypertonic saline on bacterial translocation in controlled hemorrhagic shock. Shock 15:307-311, 2001.
2. Alverdy JC, Aoys E, Moss GS: Total parenteral nutrition promotes bacterial translocation from the gut. Surgery 104:185-190, 1988.
3. Gennari R, Alexander JW, Boyce ST, et al.: Effects of the angiotensin converting enzyme inhibitor enalapril on bacterial translocation after thermal injury and bacterial challenge. Shock 6:95-100, 1996.
4. Hendrickson BA, Guo J, Laughlin R, et al.: Increased type 1 fimbrial expression among commensal Escherichia coli isolates in the murine cecum following catabolic stress. Infect Immun 67:745-753, 1999.
5. Lichtman SM: Bacterial [correction of baterial] translocation in humans. J Pediatr Gastroenterol Nutr 33:1-10, 2001.
6. Deitch EA, Berg R: Bacterial translocation from the gut: a mechanism of infection. J Burn Care Rehabil 8:475-482, 1987.
7. Deitch EA, Maejima K, Berg R: Effect of oral antibiotics and bacterial overgrowth on the translocation of the GI tract microflora in burned rats. J Trauma 25:385-392, 1985.
8. Nieuwenhuijzen GA, Deitch EA, Goris RJ: Infection, the gut and the development of the multiple organ dysfunction syndrome. Eur J Surg 162:259-273, 1996.
9. Hassoun HT, Kone BC, Mercer DW, et al.: Post-injury multiple organ failure: the role of the gut. Shock 15:1-10, 2001.
10. Moore FA, Moore EE, Poggetti R, et al.: Gut bacterial translocation via the portal vein: a clinical perspective with major torso trauma. J Trauma 31:629-636; discussion 636-638, 1991.
11. MacFie J: Enteral versus parenteral nutrition: the significance of bacterial translocation and gut-barrier function. Nutrition 16:606-611, 2000.
12. Juvonen PO, Alhava EM, Takala JA: Gut permeability in patients with acute pancreatitis. Scand J Gastroenterol 35:1314-1318, 2000.
13. Page CP, Bohnen JM, Fletcher JR, et al.: Antimicrobial prophylaxis for surgical wounds: guidelines for clinical care. Arch Surg 128:79-88, 1993.
14. Kernodle DS, Kaiser AB. Prophylaxis for gastrointestinal surgery. In Blaser MJ, Smith PD, Ravdin JI, Chaudry, IH (eds): Infections of the Gastrointestinal Tract. New York: Raven Press, 1995, pp 1329-1343.
15. Alverdy J, Holbrook C, Rocha F, et al.: Gut-derived sepsis occurs when the right pathogen with the right virulence genes meets the right host: evidence for in vivo virulence expression in Pseudomonas aeruginosa. Ann Surg 232:480-489, 2000.
16. Kinney KS, Austin CE, Morton DS, et al.: Catecholamine enhancement of Aeromonas hydrophila growth. Microb Pathog 26:85-91, 1999.
17. Lyte M, Ernst S: Catecholamine induced growth of gram negative bacteria. Life Sci 50:203-212, 1992.
18. Freestone PP, Haigh RD, Williams PH, et al.: Stimulation of bacterial growth by heat-stable, norepinephrine-induced autoinducers. FEMS Microbiol Lett 172:53-60, 1999.
19. Rahman H, Reissbrodt R, Tschape H: Effect of norepinephrine on growth of Salmonella and its enterotoxin production. Indian J Exp Biol 38:285-286, 2000.
20. Lyte M, Frank CD, Green BT: Production of an autoinducer of growth by norepinephrine cultured Escherichia coli O157:H7. FEMS Microbiol Lett 139: 155-159, 1996.
21. Lyte M, Arulanandam BP, Frank CD: Production of Shiga-like toxins by Escherichia coli O157:H7 can be influenced by the neuroendocrine hormone norepinephrine. J Lab Clin Med 128:392-398, 1996.
22. Lyte M, Erickson AK, Arulanandam BP, et al.: Norepinephrine-induced expression of the K99 pilus adhesin of enterotoxigenic Escherichia coli. Biochem Biophys Res Commun 232:682-686, 1997.
23. Neal CP, Freestone PP, Maggs AF, et al.: Catecholamine inotropes as growth factors for Staphylococcus epidermidis and other coagulase-negative staphylococci. FEMS Microbiol Lett 194:163-169, 2001.
24. Nguyen KT, Lyte M: Norepinephrine-induced growth and alteration of molecular fingerprints in Escherichia coli O157:H7. Adv Exp Med Biol 412:265-267, 1997.
25. Freestone PP, Lyte M, Neal CP, et al.: The mammalian neuroendocrine hormone norepinephrine supplies iron for bacterial growth in the presence of transferrin or lactoferrin. J Bacteriol 182:6091-6098, 2000.
26. Sears HJ, Brownlee I, Uchigama JK: Persistence of individual strains of Escherichia coli in the intestinal tract of man. J Bacteriol 59:293-301, 1949.
27. Wilson KH: Biota of the human gastrointestinal tract. In Mackie RI, White BA, Isaacson RE (eds): Gastrointestinal Microbiology, Vol. 2. New York: Chapman and Hall, 1997, pp 39-58.
28. Meirieu O, Pairet M, Sutra JF, et al.: Local release of monoamines in the gastrointestinal tract: an in vivo study in rabbits. Life Sci 38:827-834, 1986.
29. Mezey E, Eisenhofer G, Hansson S, et al.: Non-neuronal dopamine in the gastrointestinal system. Clin Exp Pharmacol Physiol Suppl 26:S14-S22, 1999.
30. Mezey E, Eisenhofer G, Harta G, et al.: A novel nonneuronal catecholaminergic system: exocrine pancreas synthesizes and releases dopamine. Proc Natl Acad Sci USA 93:10377-10382, 1996.
31. Eldrup E, Richter EA: DOPA, dopamine, and DOPAC concentrations in the rat gastrointestinal tract decrease during fasting. Am J Physiol Endocrinol Metab 279:E815-E822, 2000.
32. Gaudin C, Ruget G, Selz F, et al.: Free and conjugated catecholamines in digestive tissues of rats. Life Sci 37:1469-1474, 1985.
33. Leinhardt DJ, Arnold J, Shipley KA, et al.: Plasma NE concentrations do not accurately reflect sympathetic nervous system activity in human sepsis. Am J Physiol 265:E284-E288, 1993.
34. Blaes N, Boissel JP: Growth-stimulating effect of catecholamines on rat aortic smooth muscle cells in culture. J Cell Physiol 116:167-172, 1983.
35. Mimura Y, Kobayashi S, Notoya K, et al.: Activation by α1-adrenergic agonists of the progression phase in the proliferation of primary cultures of smooth muscle cells in mouse and rat aorta. Biol Pharm Bull 18:1373-1376, 1995.
36. Gornikiewicz A, Sautner T, Brostjan C, et al.: Catecholamines up-regulate lipopolysaccharide-induced IL-6 production in human microvascular endothelial cells. FASEB J 14:1093-1100, 2000.
37. Murphy CJ, Campbell S, Araki-Sasaki K, et al.: Effect of norepinephrine on proliferation, migration, and adhesion of SV-40 transformed human corneal epithelial cells. Cornea 17:529-536, 1998.
38. Latifi S, Lidsky K, Blumer JL: Pharmacology of inotropic agents in infants and children 12:57-79, 2000.
39. Alexander N, Yoneda S, Vlachakis ND, et al.: Role of conjugation and red blood cells for inactivation of circulating catecholamines. Am J Physiol 247:R203-R207, 1984.
40. Wooldridge KG, Williams PH: Iron uptake mechanisms of pathogenic bacteria. FEMS Microbiol Rev 12:325-348, 1993.
41. Lyte M: The role of microbial endocrinology in infectious disease. J Endocrinol 137:343-345, 1993.
42. Lyte M, Bailey MT: Neuroendocrine-bacterial interactions in a neurotoxin-induced model of trauma. J Surg Res 70:195-201, 1997.
43. Woolf PD, McDonald JV, Feliciano DV, et al.: The catecholamine response to multisystem trauma. Arch Surg 127:899-903, 1992.
44. Zetterström BEM, Palmerio C, Fine J: Changes in tissue content of catechol amines in traumatic shock. Acta Chir Scand 128:13-19, 1964.
45. Eisenhofer G, Aneman A, Hooper D, et al.: Mesenteric organ production, hepatic metabolism, and renal elimination of norepinephrine and its metabolites in humans. J Neurochem 66:1565-1573, 1996.
46. Yang S, Koo DJ, Zhou M, et al.: Gut-derived norepinephrine plays a critical role in producing hepatocellular dysfunction during early sepsis. Am J Physiol Gastrointest Liver Physiol 279:G1274-G1281, 2000.
47. Wang P, Tait SM, Chaudry IH: Sustained elevation of norepinephrine depresses hepatocellular function. Biochim Biophys Acta 1535:36-44, 2000.
48. Helton WS, Rockwell M, Garcia RM, et al.: TPN-induced sympathetic activation is related to diet, bacterial translocation, and an intravenous line. Arch Surg 130:209-214, 1995.
49. Smythe MA, Melendy S, Jahns B, et al.: An exploratory analysis of medication utilization in a medical intensive care unit. Crit Care Med 21:1319-1323, 1993.
50. Ahlman H, Bhargava HN, Dahlstrom A, et al.: On the presence of serotonin in the gut lumen and possible release mechanisms. Acta Physiol Scand 112:263-269, 1981.
51. Eisenhofer G, Coughtrie MW, Goldstein DS: Dopamine sulphate: an enigma resolved. Clin Exp Pharmacol Physiol Suppl 26:S41-S53, 1999.